Clinical Trial: Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)
Study Status: Completed
Recruit Status: Completed
Study Type: Observational
Official Title: A Cross-sectional, Retrospective Screening and Case-control Study Examining the Frequency of, and Risk Factors Associated With, Impulse Control Disorders in Parkinson's Di
Brief Summary: The purpose is to explore the frequency of impulse control disorders in Parkinson's patients treated with different Parkinson's medications.
Detailed Summary:
Sponsor: Boehringer Ingelheim
Current Primary Outcome: Occurrence of current ImpulseControl Disorder(ICD) assessed via + res. of Modif.Massachusetts Gambling Screen,Modif.Minnesota Impulsive Disorder Interview for Sexuality,Modif.MIDI for Compulsive Buying,DSM-IV binge-eating research criteria questionnaire [ Time Frame: 6 months ]
Original Primary Outcome:
Current Secondary Outcome:
- The occurrence of a past (since onset of PD) ICD [ Time Frame: 6 months ]
- Demographic and medical history measures [ Time Frame: up to 14 days after Visit 1 ]
- Scores on psychiatric/neuropsychological instruments/tests [ Time Frame: up to 14 days after Visit 1 ]
Original Secondary Outcome:
Information By: Boehringer Ingelheim
Dates:
Date Received: February 5, 2008
Date Started: September 2006
Date Completion:
Last Updated: November 11, 2013
Last Verified: November 2013
